Understanding how tau protein interacts with actin and its effects on Alzheimer's disease

Elucidating the Effects of Post-Translational Modifications on Tau Binding to F-actin and PSD95

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-10979147

This study is looking at how a protein called tau behaves in Alzheimer's disease and how changes to tau might affect its interactions with other proteins, with the goal of finding new ways to help improve treatments for people living with Alzheimer's.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10979147 on NIH RePORTER

What this research studies

This research investigates the role of tau protein in Alzheimer's disease, particularly how it binds to actin filaments and a protein called PSD-95. The study aims to uncover the effects of various chemical modifications on tau, which may influence its interactions and contribute to neurodegeneration. By exploring these mechanisms, the research seeks to identify new therapeutic targets that could improve treatment outcomes for patients with Alzheimer's disease. The approach involves laboratory experiments to analyze tau's behavior in the presence of different post-translational modifications.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related tauopathies.

Not a fit: Patients with non-tau related neurodegenerative conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating Alzheimer's disease by targeting tau-related pathways.

How similar studies have performed: Previous research has shown promising results in understanding tau interactions, but this specific approach is relatively novel.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.